| Abstrakt: |
Tristent Development SAS has been issued a patent for a delivery system for a bifurcated stent, which is used to treat intracranial aneurysms. The current methods for treating these aneurysms have limitations, especially for bifurcation aneurysms. The patented delivery system aims to overcome these limitations by providing a new therapy option. The system includes a delivery catheter with a bifurcated part that can accommodate the stent, allowing for precise placement and deployment. The document provides detailed information about the delivery system and its components, including a slit in the catheter that allows the stent to be passed through it. The method for using the delivery system involves advancing the catheter to the treatment site and deploying the stent. The document also mentions that the stent can be self-expanding and may contain medication. [Extracted from the article] |
